MONCYTE Health diagnostics, developing proprietary technology to optimize treatment and prevention of cardiovascular disease, has closed a EUR 1 million seed round to fund its go-to-market strategy.
“We see that MONCYTE Health’s innovation is a great leap in the treatment of high cholesterol, which is a major public health challenge. We invest in companies, where great health benefits meet great ...